Lesaka Technologies (LSAK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Jul, 2026Executive summary
Special Meeting of Shareholders scheduled for August 3, 2026, to approve a share option grant to Executive Chairman Ali Mazanderani in compliance with Nasdaq Listing Rule 5635(c).
The Option Award allows Mr. Mazanderani to purchase 1,000,000 shares at $5.00 per share, vesting on April 1, 2028, and exercisable after April 1, 2029, if he remains employed through the vesting date.
The Board believes the award aligns Mr. Mazanderani’s interests with shareholders and incentivizes long-term performance.
If shareholders do not approve the grant, the option will be forfeited.
Voting matters and shareholder proposals
Only one proposal is up for vote: approval of the share option grant to Mr. Mazanderani.
Approval requires more votes in favor than against; abstentions and broker non-votes do not affect the outcome.
Shareholders of record as of June 15, 2026, are eligible to vote; special instructions apply for South African shareholders.
Shareholder proposals and director nominations for the 2026 annual meeting must be submitted by June 29, 2026.
Board of directors and corporate governance
The Board unanimously recommends voting FOR the share option agreement proposal.
The Option Award will be administered by the Board or its remuneration committee, with authority to interpret and apply the agreement.
Latest events from Lesaka Technologies
- Revenue up 7% to $145.5M, EBITDA up 12%, and Adumo acquisition expands scale.LSAK
Q1 20258 Jul 2026 - Record net revenue and EBITDA growth in ZAR, with major acquisitions and debt refinancing completed.LSAK
Q3 20258 Jul 2026 - Integrated fintech platform in Southern Africa delivers strong growth and expands through strategic acquisitions.LSAK
Corporate presentation2 Jul 2026 - Vote sought on a major share option grant to the Executive Chairman, with long-term vesting.LSAK
Proxy filing22 Jun 2026 - Q3 FY2026 saw 16% revenue growth, 45% EBITDA rise, and a raised full-year outlook.LSAK
Q3 202613 May 2026 - Net revenue up 16% and Adjusted EBITDA up 47%, with first positive net income since 2022.LSAK
Q2 202617 Apr 2026 - FY2025 saw robust growth and FY2026 EPS is expected to more than double.LSAK
Q4 202510 Mar 2026 - FY 2024 EBITDA up 55%, profitability improved, and FY 2025 guidance signals >30% growth.LSAK
Q4 202420 Jan 2026 - Resale of shares from a major fintech acquisition enables liquidity for sellers, not new capital.LSAK
Registration Filing16 Dec 2025